Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRC Autologous Bone Marrow Cells for Fracture Non-Union
NCT00424567Phase 2Terminated
- Sponsor
- Vericel
- Start
- Oct 2003
- Modality
- Mesenchymal Stem Cells, Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of ixmyelocel-T in fracture nonunion, sponsored by Vericel. Started Oct 2003; status: terminated.
02
Drugs
ixmyelocel-T
03
Conditions
fracture nonunion
Beyond the preview
Go deeper on NCT00424567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00424567.